Sign In
Buy AZTA
$29.37
-0.380 (-1.28%)
At Close: Nov 17, 2025
Envestnet Asset Management Inc. Has $3.51 Million Stake in Azenta, Inc. $AZTA
04:23am, Sunday, 16'th Nov 2025
Envestnet Asset Management Inc. decreased its stake in shares of Azenta, Inc. (NASDAQ: AZTA) by 65.0% during the undefined quarter, according to the company in its most recent filing with the SEC. The
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast
04:05pm, Wednesday, 12'th Nov 2025
BURLINGTON, Mass. , Nov. 12, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21,
Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer
04:05pm, Tuesday, 04'th Nov 2025
BURLINGTON, Mass. , Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative fo
Yousif Capital Management LLC Sells 2,421 Shares of Azenta, Inc. $AZTA
03:49am, Friday, 24'th Oct 2025
Yousif Capital Management LLC lowered its stake in Azenta, Inc. (NASDAQ: AZTA) by 14.0% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 14,90
Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana
08:00am, Wednesday, 15'th Oct 2025
BURLINGTON, Mass. , Oct. 15, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Wednesday, December 10, 2025, at the Company's biorepository facility
Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript
03:11pm, Tuesday, 05'th Aug 2025
Azenta, Inc. (NASDAQ:AZTA ) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants John P. Marotta - President, CEO & Director Lawrence Y.
Azenta (AZTA) Q3 EPS Jumps 36%
02:05pm, Tuesday, 05'th Aug 2025
Azenta (AZTA) Q3 EPS Jumps 36%
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance
06:30am, Tuesday, 05'th Aug 2025
BURLINGTON, Mass. , Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025.
BURLINGTON, Mass. , July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics
Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences Provides vital insights through sophisticated geno
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
04:05pm, Wednesday, 30'th Jul 2025
BURLINGTON, Mass. , July 30, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conf
Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast
04:05pm, Wednesday, 23'rd Jul 2025
BURLINGTON, Mass. , July 23, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2025 earnings which ended on June 30, 2025, on Tuesday August 5, 2025, before the marke
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development
04:05pm, Tuesday, 13'th May 2025
Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. BURLINGTON, Mass.
Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript
01:44pm, Wednesday, 07'th May 2025
Azenta, Inc. (NASDAQ:AZTA ) Q2 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Yvonne Perron - Vice President, Financial Planning & Analysis and Investor Relations John Marot
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025
06:30am, Wednesday, 07'th May 2025
BURLINGTON, Mass. , May 7, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2025.
